Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 20003;
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 20003;
The Center for Drug Reevaluation and The Center for Adverse Drug Reaction Monitoring, State Food and Drug Administration, Beijing 100061, China;
The Center for Drug Reevaluation and The Center for Adverse Drug Reaction Monitoring, State Food and Drug Administration, Beijing 100061, China;
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 20003;
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 20003;
Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 20003;
non-steroidal anti-inflammatory drugs; adverse drug reaction; risk factors; retrospective studies; quality of life;